Online:
Visits:
Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Ragweed Pollen Allergy – Pipeline Review, H1 2017

Monday, March 20, 2017 2:45
% of readers think this story is Fact. Add your two cents.

(Before It's News)

 

Ethocle Reports has published its latest Market Research Report on Ragweed Pollen Allergy – Pipeline Review, H1 2017. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Browse market data tables and figures.

                                                                                     

                                                                                                         Published On: 15-Mar-2017 | Pages: 26

Summary

Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy – Pipeline Review, H1 2017, provides an overview of the Ragweed Pollen Allergy (Immunology) pipeline landscape.

Ragweed allergy occurs when ragweed pollen in the air enters the nose and throat of people who are allergic to that pollen, it can cause allergy and asthma symptoms. Symptoms include sneezing, runny or stuffy nose, itchy throat or inside of ears, hives, and swollen eyelids and itchy eyes. Treatment includes decongestant, antihistamine and nasal corticosteroid.

Capture.PNG      dd.PNG      d.PNG

Report Highlights

Pharmaceutical and Healthcare latest pipeline guide Ragweed Pollen Allergy – Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Ragweed Pollen Allergy (Immunology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Ragweed Pollen Allergy (Immunology).

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Ragweed Pollen Allergy (Immunology) therapeutics and enlists all their major and minor projects.

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Ragweed Pollen Allergy (Immunology).

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

Introduction

Global Markets Direct Report Coverage

Ragweed Pollen Allergy – Overview

Anergis SA

ASIT Biotech SA

Astellas Pharma Inc

Biomay AG

Ragweed Pollen Allergy – Drug Profiles

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.